Bioinformatics and Advanced Analytics Powering Drug Discovery

USD 950

* Required Fields

USD 950


Be the first to review this product

Personalized medicine has brought forth a new avenue for innovation. Currently, genomics is being accelerated into extensive use across drug development and drug discovery. The capability of genomics has brought about the resurgence of biomarkers that could effective patient stratification, ensuring the right drugs are developed to treat a specific type of disease.

The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders.

The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Precision oncology, genomics, personalized medicine, glycoproteomics, circulating tumor cells, biomarkers, ALS, malaria

Table of Contents

Bioinformatics and Advanced Analytics Powering Drug DiscoveryInnovations Aimed at Accelerating Drug Discovery and DevelopmentGenomics-based Molecular Diagnostics Driving Precision OncologyNext-generation Screening and Diagnostics for Personalized MedicineGlycoproteomics Approach Leveraging Biotech and High-tech InnovationHighly Accurate Circulating Tumor Cells (CTC) BiomarkersLeveraging Deep Learning Platforms to Accelerate Drug DevelopmentNovel Drug for ALS Treatment Receives Regulatory ApprovalNovel Drug with a Potential to Eradicate MalariaDrug Discovery Technology Focus and TrendsTechnology Focus and TrendsThree Start Ups to NoteIndustry InteractionsIndustry Interactions (continued)




Related Research

Release Date : 29-Dec-17

Region : Global

Release Date : 29-Dec-17

Region : Global

Release Date : 31-Oct-17

Region : Global

Release Date : 19-May-17

Region : Global

Related Subscription

• One-2-One Analyst briefing call •
• Access to published and new research deliverables •
• Mid year service review •
• Virtual Analyst briefing •
• GIL conference seats •

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.